Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Reliq Health Technologies Inc V.RHT

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a Canada-based global healthcare technology company that specializes in developing virtual care solutions. The Company's target markets include virtual care, long-term care and big data. iUGO Care, the Company's platform, is a software as a service solution that supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, remote therapeutic monitoring and wound care. Its behavioral health integration service supports patients with any mental, behavioral, or psychiatric health diagnoses by integrating mental health, psychiatric care, counseling, and addiction services with primary care.


TSXV:RHT - Post by User

Post by NobleFron May 29, 2020 11:30am
155 Views
Post# 31087832

Covid-19 Argument is Valid

Covid-19 Argument is ValidI was a strong believer in good Q3 results from Lisa and I am very disappointed with the actual financials.

At first, I thought that because they could onboard remotely, the lockdown had no impact on them. In the end, I guess her argument that the clinicians were overwhelmed and had other priorities is valid...

This would mean that April is probably as dramatic as March and could lead to very bad Q4 results... It could be why she doesn't want to give us current numbers. The higher the share price, the less dilution for us. I could understand why she could want to delay bad news as long as possible.

The "hope" I have is the massive pipeline they have. As long as the demand is there, it shows they have a good product. The quality of their product is what matters here. I have no idea how they will go from 400k/quarter revenue to their potential 200m+/year but even if they reach 1/10 of that objective the company will be worth more than today.

They showed they could sign 100k+ patients so I believe they can sign 500k+. They still have to show me how they can onboard 100k+ tho...



Bullboard Posts